Pharmacoeconomics Nathorn Chaiyakunapruk, PharmD PhD; David Wu, PhD; Chayanin Pratoomsoot; Kenneth Lee PhD; Huey Chong Yi; Richard E. Nelson PhD; Patrick Smith, PharmD; Carl Kirkpatrick, PhD; Mohamed Kamal, PharmD PhD; Keith Nieforth, PharmD; Georgina Dall, PharmD; Stephen Toovey, MD PhD; David Kong, PhD; Aaron Kamauu, MD MS MPH; Craig Rayner, PharmD MBA; Monash University, Selangor, Malaysia; ...

In a comment to our article entitled ‘‘Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review’’, which was recently published in PharmacoEconomics Open [1], Holko stated that marketspecific aspects could affect efficiency of forecasting price using the price of a close substitute [2]. We thank the author for the comment on our article and agree that there a...

1 Department of PharmacoEpidemiology and PharmacoEconomics (PE 2 ), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, THE NETHERLANDS 2 Department of Epidemiology, Oncology Institute of Vojvodina, Put dr Goldmana 4, 21024 Sremska Kamenica, SERBIA 3 Department of Epidemiology, Medical Faculty, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, SERBIA 4 Department for pr...

Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications Nihar R. Desai, MD, MPH, William H. Shrank, MD, MSHS, Michael A. Fischer, MD, MS, Jerry Avorn, MD, Joshua N. Liberman, PhD, Sebastian Schneeweiss, MD, ScD, Juliana Pakes, MEd, Troyen A. Brennan, MD, JD, MPH, Niteesh K. Choudhry, MD, PhD Divisions of Pharmacoepidemiology and Pharmacoeconomics an...